Examining A Phase 1 COVID-19 Clinical Trial

In this case study, the global Clinical Research Organization (CRO) Novotech played a crucial role in successfully managing a Phase I clinical trial for a new oral antiviral treatment for COVID-19 in New Zealand. The company provided strategic insights, regulatory guidance, and operational assistance, enabling the trial to progress smoothly despite the challenges posed by the pandemic.

Uncover how Novotech efficiently activated the site and enrolled 130 participants within six months, demonstrating their expertise in clinical trial management. The partnership between Novotech and the biotech sponsor facilitated a seamless transition from Phase I to Phase II, highlighting the importance of collaboration in conducting clinical trials during the COVID-19 pandemic.